(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
February 2021

Dr. Stephen L. Mayo Elected to Merck’s Board of Directors

Merck has appointed Dr. Stephen (“Steve”) L. Mayo to its Board of Directors, commencing on March 15, 2021. His appointment will increase the number of Board Members to 14. Steve is currently the Bren Professor of Biology and Chemistry at the California Institute of Technology (Caltech). He has previously served Caltech in several capacities over nearly two decades, in such positions as Chair of the Division of Biology & Biological Engineering and Vice Provost. 

Merck, known as MSD outside of the U.S. and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of its mission to save and improve lives. Based in Kenilworth, NJ, the company employs about 57,000 individuals. For 2019, Merck reported revenues of $46.84 billion.